Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

10 Nov 2022 09:42

RNS Number : 9939F
Mandarin Oriental International Ltd
10 November 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

10th November 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2022.

 

The return of normal travel conditions in most of the world in early 2022 saw the Group record net underlying profits (unaudited) in the second quarter, and this progress continued in the third quarter.

 

In the Group's owned hotels, improvements in occupancy and high rates resulted in a stronger performance in the third quarter. This drove increased profitability compared to the second quarter, particularly in Paris and Munich. Two of the Group's key profit-generating hotels, in Hong Kong and Tokyo, however, remained subject to stringent travel restrictions throughout the third quarter, which significantly impacted operating performance. The hotels in Bangkok and Singapore continued their recovery following the removal of travel barriers.

 

The performance of the management business was strong in the third quarter and it recorded a significant improvement in profitability compared to the second quarter. Of particular note were the contributions made by a number of the Group's Mediterranean and Middle Eastern properties.

 

As a result of the improved trading conditions and Mandarin Oriental's expanded portfolio of hotels and residences, the Group recorded its highest quarterly EBITDA since 2019. Both the owned hotels and the management business delivered higher EBITDA than in the second quarter of 2022.

 

In September 2022, the Group opened Mandarin Oriental Palace, Luzern, its second hotel in Switzerland, and its standalone residences project in Barcelona. Recently, the Group announced a new hotel in Tianfu, the new business district of Chengdu, further expanding its presence in China. On 8th September 2022, the Group completed the sale of Mandarin Oriental, Washington D.C., for US$139 million. As a result, the Group has recognised a post-tax, non-trading gain in the third quarter of US$47 million.

 

Following the disposal, net debt at 30th September 2022 reduced to US$385 million (US$519 million at 30th June 2022), and the Group held US$267 million of cash reserves and US$472 million in available, committed debt facilities. Gearing was 8% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKBLBFLFLXFBK
Date   Source Headline
14th May 201812:08 pmRNSDirector/PDMR Shareholding
11th May 201810:12 amRNSDirector Declaration
9th May 20182:47 pmRNSDirectorate Change
9th May 20182:34 pmRNSNon-Routine Resolutions submitted via NSM
9th May 20182:19 pmRNSResult of AGM
9th May 201812:32 pmRNSInterim Management Statement
3rd May 201811:03 amRNSDirector/PDMR Shareholding
2nd May 201811:15 amRNSDirector/PDMR Shareholding
2nd May 201810:34 amRNSDividend
30th Apr 201810:54 amRNSTotal Voting Rights
25th Apr 201810:51 amRNSDirector/PDMR Shareholding
12th Apr 201810:49 amRNSAnnual Financial Report
29th Mar 201810:28 amRNSTotal Voting Rights
26th Mar 201810:34 amRNSBlock listing Interim Review
19th Mar 201811:11 amRNSDirector/PDMR Shareholding
14th Mar 20187:38 amRNSAdditional Listing
12th Mar 20189:16 amRNSDirector/PDMR Shareholding
8th Mar 20189:07 amRNS2017 PRELIMINARY ANNOUNCEMENT OF RESULTS
7th Feb 20189:14 amRNSNotice of 2017 Final Results
31st Jan 201810:33 amRNSTotal Voting Rights
16th Jan 201810:07 amRNSDirector/PDMR Shareholding
27th Dec 20179:39 amRNSDirector/PDMR Shareholding
21st Dec 201710:06 amRNSDirector/PDMR Shareholding
1st Dec 20179:58 amRNSDirector/PDMR Shareholding
30th Nov 20179:21 amRNSDirector/PDMR Shareholding
30th Nov 20179:17 amRNSTotal Voting Rights
31st Oct 20179:12 amRNSTotal Voting Rights
25th Oct 201711:15 amRNSDirector/PDMR Shareholding
4th Oct 201710:11 amRNSDividend
3rd Oct 201711:25 amRNSDirector/PDMR Shareholding
29th Sep 201711:09 amRNSDirector/PDMR Shareholding
27th Sep 20177:31 amRNSUpdate Review:Long-term Strategic Options for EXHK
25th Sep 201710:14 amRNSBlock listing Interim Review
15th Sep 201710:11 amRNSMO-Review of Long-term Strategic Options for EXHK
3rd Aug 201710:06 amRNSHalf Yearly Results
6th Jul 201710:15 amRNSNotice of 2017 Half-Yearly Results
5th Jun 20177:00 amRNSMO to Review Long-term Strategic Options for EXHK
3rd May 20172:13 pmRNSNon-Routine Resolutions submitted via NSM
3rd May 20172:01 pmRNSResult of AGM
3rd May 201712:35 pmRNSInterim Management Statement
28th Apr 201710:10 amRNSTotal Voting Rights
26th Apr 201710:40 amRNSDividend
5th Apr 201710:16 amRNSAnnual Financial Report
31st Mar 201710:42 amRNSTotal Voting Rights
27th Mar 201710:13 amRNSBlock listing Interim Review
27th Mar 201710:10 amRNSDirector/PDMR Shareholding
14th Mar 201711:04 amRNSDirector/PDMR Shareholding
3rd Mar 20178:06 amRNSAdditional Listing
2nd Mar 20179:06 amRNS2016 PRELIMINARY ANNOUNCEMENT OF RESULTS
1st Feb 20179:40 amRNSNotice of 2016 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.